Market Overview

C.K. Cooper & Company Reiterates Buy on DUSA Pharmaceuticals, Inc., Maintains $9.50 PT

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for DUSA

DateFirmActionFromTo
Dec 2012C.K. Cooper & CompanyReiterates
Mar 2012CK CooperInitiates Coverage onBuy

View More Analyst Ratings for DUSA
View the Latest Analyst Ratings

Posted-In: News Reiteration Analyst Ratings

 

Related Articles (DUSA)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters